Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

David Tougeron; Maxime Hentzien; Barbara Seitz‐Polski; Firouzé Bani‐Sadr; Jean Bourhis; Michel Ducreux; Sébastien Gaujoux; Philippe Gorphe; Boris Guiu; Khê Hoang‐Xuan; F. Huguet; Thierry Lecomte; Astrid Lièvre; Christophe Louvet; Léon Maggiori; Laura Mansi; Pascale Mariani; Pierre Michel; Amélie Servettaz; Juliette Thariat; V. Westeel; Thomas Aparicio; Jean Yves Blay; Olivier Bouché

doi:10.1016/j.ejca.2021.03.030

Article2021

SARS-CoV-2 vaccination for patients with solid cancer: review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER)

David Tougeron, Maxime Hentzien, Barbara Seitz‐Polski, Firouzé Bani‐Sadr, Jean Bourhis, Michel Ducreux, Sébastien Gaujoux, Philippe Gorphe, Boris Guiu, Khê Hoang‐Xuan, F. Huguet, Thierry Lecomte, Astrid Lièvre, Christophe Louvet, Léon Maggiori, Luigi Mansi, Pascale Mariani, Pierre Michel, Amélie Servettaz, Juliette Thariat, Westeel, T. Aparicio, Jean Yves Blay, Olivier Bouché, réseau de groupes coopérateurs en oncologie, Fédération nationale des centres de lutte contre le cancer, Fédération francophone de cancérologie digestive, Groupe Coopérateur multidisciplinaire en Oncologie, Groupe d'Oncologie Radiothérapie Tête et Cou-Intergroupe Orl, intergroupe francophone de cancérologie thoracique, InterGroupe Coopérateur de Neuro-Oncologie, Société française de chirurgie digestive, Société française d’endoscopie digestive, Société française de radiothérapie oncologique, Société Française de Radiologie, Société Nationale Française de Colo-Proctologie, Société Nationale Française de Gastro-Entérologie.

Article2022

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

Harry Alexopoulos, Ioannis P. Trougakos, Meletios A Dimopoulos, Evangelos Terpos

Article2020

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Chuanhao Jiang, Yali Wang, Min Hu, Lingjun Wen, Chuan Wen, Yang Wang, Weihong Zhu, Shi Tai, Zhongbiao Jiang, Kui Xiao, Nuno R. Faria, De Clercq Erik, Junmei Xu, Guangdi Li

Article2020

Assessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies

Vincent P. Kuiper, Frits R. Rosendaal, Ingrid M. C. Kamerling, Leo G. Visser, Meta Roestenberg

Clinical Infectious Diseases

Preprint2020

Epitope-based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2

Ahmed Rakib, Saad Ahmed Sami, Md. Ashiqul Islam, Shahriar Ahmed, Farhana Binta Faiz, Bibi Humayra Khanam, Kay Kay Shain Marma, Maksuda Rahman, Mir Muhammad Nasir Uddin, Talha Bin Emran, Jesus Simal Gandara

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

Discussion(0)

Related publications

SARS-CoV-2 vaccination for patients with solid cancer: review and point of view of a French oncology inter-group (CGO, TNCD, UNICANCER)

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies

Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

Assessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies

Epitope-based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2